- Professionali
- Alzheimer’s disease (ad) remains one of the most pressing public health challenges of our time, with rising prevalence due to global population aging and no definitive cure currently available. Traditionally considered a uniform clinical entity, ad is now recognized as a biologically heterogeneous condition with diverse trajectories, underpinned by complex interactions between genetic, molecular, environmental, and lifestyle factors.
The era of precision medicine has opened a new frontier in the fight against alzheimer’s disease. By shifting from a one-size-fits-all approach to a model that considers individual variability in genes, biomarkers, and disease progression, precision medicine offers the promise of earlier diagnosis, more accurate risk stratification, and tailored therapeutic strategies.